Last updated: July 17, 2026

Application No. 17/625,973

A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE

Final Rejection

Filed

Jan 10, 2022

Priority

Jul 16, 2019 — SE 1950898-5 +2 more

Examiner

CABRAL, ROBERT S

Art Unit

1614

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Fluoguide A/S

OA Round

2 (Final)

Interview Optional

— +32.5% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 62% grant rate with +32.5% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 859 resolved cases, 2023–2026

Examiner Intelligence

CABRAL, ROBERT S View full profile →

Grants 62% of resolved cases

Career Allowance Rate

537 granted / 859 resolved

+2.5% vs TC avg

Strong +32% interview lift

Without

With

+32.5%

Interview Lift

resolved cases with interview

Typical timeline

5y 7m

Avg Prosecution

26 currently pending

Career history

890

Total Applications

across all art units

Statute-Specific Performance

§101

0.6%

-39.4% vs TC avg

§103

63.2%

+23.2% vs TC avg

§102

8.8%

-31.2% vs TC avg

§112

10.1%

-29.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 859 resolved cases

Prosecution Timeline

Show 1 earlier event

Apr 10, 2025

Non-Final Rejection mailed

May 30, 2025

Response Filed

Nov 29, 2025

Examiner Interview (Telephonic)

Dec 19, 2025

Examiner Interview Summary

Apr 15, 2026

Response after Non-Final Action

May 14, 2026

Request for Continued Examination

May 19, 2026

Response after Non-Final Action

Jun 23, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/756,689

Patent 12678518

A Theranostic Probe and its Use for Targeting and/or Labeling the EGFR Kinase and/or the Cells Expressing EGFR or its Family Members

4y 1m to grant Granted Jul 14, 2026

18/019,564

Patent 12673120

Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof

3y 5m to grant Granted Jul 07, 2026

18/587,211

Patent 12655237

SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF

2y 3m to grant Granted Jun 16, 2026

17/789,036

Patent 12649776

SCAFFOLD PROTEINS AND THERAPEUTIC NANOCONJUGATES BASED ON NIDOGEN

3y 11m to grant Granted Jun 09, 2026

17/924,369

Patent 12643855

FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS

3y 6m to grant Granted Jun 02, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

62%

Grant Probability

95%

With Interview (+32.5%)

5y 7m (~1y 0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 859 resolved cases by this examiner. Grant probability derived from career allowance rate.